About this trial
This randomized, parallel-group, non-inferiority clinical trial aims to evaluate whether an anesthetic swap strategy consisting of sevoflurane followed by desflurane 30 minutes before the end of surgery is non-inferior to continuous desflurane anesthesia with respect to extubation time in adults undergoing elective laparoscopic bariatric surgery. Secondary outcomes include time to achieve a Patient State Index (PSi) greater than 80, time to achieve an Aldrete score of at least 8, incidence of postoperative nausea and vomiting, post-anesthesia care unit length of stay, and desflurane-related costs.
Eligibility criteria
Qualifiers
Age 18 years or older.
Scheduled for elective laparoscopic gastric bypass surgery.
Body mass index between 30 and 50 kg/m².
American Society of Anesthesiologists physical status II or III.
Disqualifiers
Surgical procedure lasting less than 2 hours.
Body mass index greater than 50 kg/m².
Significant cardiac disease.
Moderate or severe obstructive respiratory disease, including uncontrolled asthma or chronic obstructive pulmonary disease.
Trial design
Treatments tested in this trial
- Desflurane
- Sevoflurane-Desflurane